[
  {
    "uuid": "600660ea911bb34f6dd30d249a291060002a478f",
    "url": "https://daijiworld.com/news/newsDisplay?newsID=1160200",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "daijiworld.com",
    "published": "2024-01-20T01:19:00Z",
    "title": "'Machines not creative': NCC playing crucial role, says Rajnath",
    "text": "New Delhi, Jan 20 (IANS): Defence Minister Rajnath Singh on Saturday said that machines can perform physical and intellectual tasks but cannot be creative, generate consciousness or develop interpersonal skills like humans.\n“This is where the NCC is playing a crucial role,” the Defence Minister said.\nHe said that with time and further advancements, people will begin to focus more on creating a career in sectors where machines cannot execute the desired tasks.\n“Creativity, interpersonal skills, emotional intelligence and sensitivity are the qualities which will make a person relevant and employable in the present age of machines and artificial intelligence,” Singh said while addressing the NCC cadets at Delhi Cantt.\nHe appreciated the NCC for equipping the cadets with these qualities and ensuring their all-round development to lead the next generation.\n“The NCC, through its various initiatives and programmes, is ensuring holistic growth of cadets by making them physically, mentally and emotionally strong, developing their social skills and instilling the feeling of patriotism and national pride,” the Defence Minister said.\nHe said that along with studies, it is extremely important for the cadets to imbibe these qualities.\n“This will help them to give their 100 per cent in the progress of the country,” he said.\nDisclaimer:\nPlease write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.\nPlease note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.\nHence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology",
      "War, Conflict and Unrest",
      "Social Issue"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "rajnath singh",
          "sentiment": "neutral"
        },
        {
          "name": "rajnath",
          "sentiment": "neutral"
        },
        {
          "name": "singh",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "ncc",
          "sentiment": "neutral"
        }
      ],
      "locations": [
        {
          "name": "new delhi",
          "sentiment": "none"
        },
        {
          "name": "delhi cantt",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-01-20T14:51:15.902+02:00",
    "updated": "2024-01-20T14:51:15.902+02:00"
  },
  {
    "uuid": "25808cb1694fa88131c63e6c0eb791c2b2f03cff",
    "url": "https://simplywall.st/stocks/kr/pharmaceuticals-biotech/kosdaq-a166480/corestemchemon-shares/news/is-corestemchemon-kosdaq166480-using-too-much-debt",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Simply Wall St",
    "published": "2025-02-20T21:38:00Z",
    "title": "Is CORESTEMCHEMON (KOSDAQ:166480) Using Too Much Debt?",
    "text": "South Korea- /\nBiotech- /\n- KOSDAQ:A166480\nIs CORESTEMCHEMON (KOSDAQ:166480) Using Too Much Debt?\nThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We note that CORESTEMCHEMON Inc. (KOSDAQ:166480) does have debt on its balance sheet. But the real question is whether this debt is making the company risky.\nWhen Is Debt A Problem?\nGenerally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first step when considering a company's debt levels is to consider its cash and debt together.\n View our latest analysis for CORESTEMCHEMON\nWhat Is CORESTEMCHEMON's Net Debt?\nYou can click the graphic below for the historical numbers, but it shows that as of September 2024 CORESTEMCHEMON had ₩40.0b of debt, an increase on ₩27.5b, over one year. However, it does have ₩2.50b in cash offsetting this, leading to net debt of about ₩37.5b.\nA Look At CORESTEMCHEMON's Liabilities\nWe can see from the most recent balance sheet that CORESTEMCHEMON had liabilities of ₩52.6b falling due within a year, and liabilities of ₩26.6b due beyond that. Offsetting these obligations, it had cash of ₩2.50b as well as receivables valued at ₩4.63b due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by ₩72.0b.\nThis deficit is considerable relative to its market capitalization of ₩96.8b, so it does suggest shareholders should keep an eye on CORESTEMCHEMON's use of debt. Should its lenders demand that it shore up the balance sheet, shareholders would likely face severe dilution. The balance sheet is clearly the area to focus on when you are analysing debt. But it is CORESTEMCHEMON's earnings that will influence how the balance sheet holds up in the future. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.\nOver 12 months, CORESTEMCHEMON made a loss at the EBIT level, and saw its revenue drop to ₩29b, which is a fall of 29%. That makes us nervous, to say the least.\nCaveat Emptor\nNot only did CORESTEMCHEMON's revenue slip over the last twelve months, but it also produced negative earnings before interest and tax (EBIT). Indeed, it lost a very considerable ₩24b at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. Another cause for caution is that is bled ₩41b in negative free cash flow over the last twelve months. So in short it's a really risky stock. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. For example CORESTEMCHEMON has 4 warning signs (and 3 which make us uncomfortable) we think you should know about.\nAt the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.\nNew: AI Stock Screener & Alerts\nOur new AI Stock Screener scans the market every day to uncover opportunities.\n• Dividend Powerhouses (3%+ Yield)\n• Undervalued Small Caps with Insider Buying\n• High growth Tech and AI Companies\nOr build your own from over 50 metrics.\nExplore Now for Free\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.\nThis article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nAbout KOSDAQ:A166480\nCORESTEMCHEMON\nA bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.\nSlight and slightly overvalued.\nCommunity Narratives\nFiverr aims for greater revenue with expansive enterprise solutions and AI\nSoundHound’s Moat And Diversified Revenue Strategy Make It A Voice AI Leader\nEquity Analyst and Writer\nMedtronic Stock: A Compelling Buy for Value and Income Investors as Robotics, Innovation Catalysts Ignite Upside to $105+",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Economy, Business and Finance",
      "Social Issue",
      "Health"
    ],
    "topics": [
      "Economy, Business and Finance->debt market",
      "Social Issue->demographics",
      "Health->medical condition"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [
      "https://investor-research.typeform.com/to/wvg6MFri#feedback_token=MzYzMTM3NDplNWM5MDY4OGU2N2FlMzky&company=CORESTEMCHEMON&blueprintid=3631374",
      "https://www.investor-research.typeform.com/to/wvg6MFri#feedback_token=MzYzMTM3NDplNWM5MDY4OGU2N2FlMzky&company=CORESTEMCHEMON&blueprintid=3631374"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "Charlie Munger",
          "sentiment": "none"
        },
        {
          "name": "Li Lu",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "CORESTEMCHEMON Inc.",
          "sentiment": "none"
        },
        {
          "name": "Berkshire Hathaway",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-02-21T00:10:17.951+02:00",
    "updated": "2025-02-21T00:10:17.951+02:00"
  },
  {
    "uuid": "bfb37fee1079317fb73375d097a306eb0026482f",
    "url": "https://www.crossroadstoday.com/news/espanol/noticias-locales/el-consumo-de-marihuana-y-alucin-genos-se-mantiene-en-niveles-hist-ricamente-altos-entre/article_2ef0d4ee-19c2-5daa-b5ad-08bad18f7fa5.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Rocío Muñoz-Ledo",
    "published": "2024-08-30T03:20:00Z",
    "title": "El consumo de marihuana y alucinógenos se mantiene en \"niveles históricamente altos\" entre los adultos jóvenes y de mediana edad, según una encuesta | Noticias-locales | crossroadstoday.com",
    "text": "(CNN) -- El consumo de marihuana y alucinógenos \"se mantuvo en niveles históricamente altos\" entre los adultos más jóvenes y de mediana edad en Estados Unidos en 2023, de acuerdo con la más reciente encuesta de \"Monitoring the Future\", un estudio realizado por investigadores de la Universidad de Michigan desde 1975 y financiado por los Institutos Nacionales de Salud (NIH, por sus siglas en inglés).\nAproximadamente 2 de cada 5 adultos (42%) de entre 19 y 30 años declararon haber consumido marihuana el año anterior, y cerca del 10% de ese grupo afirmó consumir marihuana casi todos los días.\nPor primera vez, más mujeres de 19 a 30 años declararon consumir marihuana que hombres del mismo grupo de edad, según los datos de la encuesta. Sin embargo, hubo una mayor prevalencia de hombres que consumieron marihuana que de mujeres en el grupo de mayor edad.\nLas intoxicaciones por marihuana entre los adultos mayores se triplicaron, según un estudio\nAlrededor del 29% de los adultos de mediana edad —personas de 35 a 50 años— declararon haber consumido marihuana al menos una vez en el último año, y 8% declaró consumirlo a diario.\nSegún los investigadores, estos resultados no difieren estadísticamente de los obtenidos el año previo entre los adultos de ambos grupos de edad en 2022, pero muestran un aumento en los últimos cinco y diez años.\nEl consumo de marihuana aumentó ligeramente entre los adultos más jóvenes, ya que aproximadamente 1 de cada 5 adultos de ese grupo de edad declaró haberla consumido al menos una vez en el último año, y se mantuvo prácticamente igual entre los adultos de mediana edad, ya que aproximadamente 9% de las personas de ese grupo consumió marihuana en el último año.\nSegún el informe, el consumo de nicotina también se mantuvo elevado entre ambos grupos de adultos.\nEl consumo de alucinógenos –como LSD, mescalina, peyote, PC y hongos o psilocibina– en el último año se mantuvo en torno al mismo nivel que en 2022, con 9% entre los adultos de 19 a 30 años (frente al 8% del año anterior) y 4% entre los adultos de 35 a 50 años en 2023 y 2022.\n\"Hemos visto que las personas en diferentes etapas de la edad adulta tienden hacia el consumo de drogas como la marihuana y los psicodélicos y se alejan de los cigarrillos de tabaco\", dijo la Dra. Nora Volkow, directora del Instituto Nacional sobre el Abuso de Drogas de los NIH. \"Estos resultados subrayan la urgente necesidad de una investigación rigurosa sobre los riesgos y beneficios potenciales de la marihuana y los alucinógenos, especialmente a medida que siguen apareciendo nuevos productos\".\n¿Qué significaría que la marihuana sea considerada droga de bajo riesgo en EE.UU?\nLa sustancia más consumida entre los adultos sigue siendo el alcohol, ya que más de 4 de cada 5 adultos jóvenes (84%) declararon haber bebido en el último año. Sin embargo, el consumo frecuente de alcohol –ya sea mensual, diario o en exceso– disminuyó en 2023 con respecto a la década anterior entre los jóvenes de 19 a 30 años.\nLos investigadores también observaron otros descensos en el consumo de drogas, lo que refleja un cambio de hábitos. El consumo de cigarrillos y el uso de opiáceos y medicamentos con receta por razones no médicas \"mantuvieron los descensos de cinco y diez años\" en ambos grupos de edad.\nEn 2023, las muertes por sobredosis de drogas disminuyeron por primera vez desde 2018, de acuerdo con datos preliminares del Centro Nacional de Estadísticas de Salud de los Centros para el Control y la Prevención de Enfermedades de Estados Unidos (CDC, por sus siglas en inglés). Alrededor de 107.500 personas murieron por sobredosis de drogas en 2023, mostraron los datos, impulsados por el fentanilo y los opioides sintéticos.\nAunque solo se observaron ligeros cambios en comparación con los resultados de la encuesta \"Monitoring the Future\" del año previo, los investigadores afirman que los resultados ayudan a tener una visión más amplia, especialmente a medida que los encuestados envejecen.\n\"Los datos de 2023 no mostraron muchos cambios significativos con respecto al año anterior, pero el poder de encuestas como 'Monitoring the Future' es ver el flujo y reflujo de diversas tendencias de consumo de sustancias a largo plazo\", dijo Megan Patrick, profesora de investigación en la Universidad de Michigan e investigadora principal del estudio de panel \"Monitoring the Future\".\n\"A medida que más y más de nuestras cohortes originales –reclutadas por primera vez cuando eran adolescentes– vayan entrando en la edad adulta, podremos examinar las pautas y los efectos del consumo de drogas a lo largo de la vida. En los próximos años, este estudio proporcionará datos cruciales sobre las tendencias de consumo de sustancias y las consecuencias para la salud entre las poblaciones de mayor edad, cuando las personas pueden estar entrando en la jubilación y otros nuevos capítulos de sus vidas\".\nThe-CNN-Wire\n™ & © 2024 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.\n​THE-CNN-WIRE (TM) & © 2024 CABLE NEWS NETWORK, INC., A TIME WARNER COMPANY. ALL RIGHTS RESERVED.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Social Issue",
      "Lifestyle and Leisure"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": null,
    "rating": null,
    "crawled": "2024-08-30T17:02:20.405+03:00",
    "updated": "2024-08-30T17:02:20.405+03:00"
  },
  {
    "uuid": "cb0022330ab4bc15efa9c9c8500e42f20a68e66b",
    "url": "https://finance.sina.com.cn/money/fund/aiassistant/jzyd/2025-04-24/doc-ineuezvf9408572.shtml",
    "ord_in_thread": 0,
    "author": "sina.com.cn",
    "published": "2025-04-23T21:06:00Z",
    "title": "平安先进制造主题股票发起C净值上涨5.10%|股票_新浪财经_新浪网",
    "text": "平安先进制造主题股票型发起式证券投资基金（简称：平安先进制造主题股票发起C，代码019458）公布4月23日最新净值，上涨5.10%。\n平安先进制造主题股票发起C成立于2023年10月24日，业绩比较基准为中证智能制造主题指数收益率×85%+中证全债指数收益率×10%+恒生指数收益率(经汇率调整)×5%。该基金成立以来收益54.09%，今年以来收益46.74%，近一月收益-7.34%，近一年收益71.71%。近一年，该基金排名同类18/3543。\n基金经理为张荫先。张荫先自2023年9月22日管理（或拟管理）该基金，任职期内收益54.09%。\n最新定期报告显示，该基金前十大重仓股如下：\n股票代码 股票名称 持仓占比 持仓股数（股） 持仓市值（元） 601100 恒立液压 4.53% 752700 5986.98万 603119 浙江荣泰 4.22% 1419650 5576.39万 688433 华曙高科 3.84% 1102679 5070.12万 688322 奥比中光 3.47% 827165 4578.36万 688279 峰岹科技 3.46% 195336 4568.71万 002050 三花智控 3.36% 1538527 4435.57万 600592 龙溪股份 3.35% 2444400 4429.25万 688577 浙海德曼 3.32% 728872 4387.81万 002850 科达利 3.31% 359100 4375.63万 300852 四会富仕 3.23% 1390290 4269.58万\nMACD金叉信号形成，这些股涨势不错！",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Health",
      "Science and Technology"
    ],
    "topics": [
      "Economy, Business and Finance->financial service",
      "Economy, Business and Finance->investment and opinion pieces",
      "Science and Technology->technology and engineering",
      "Science and Technology->economics"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [
      "https://finance.sina.cn/app/sfa_macd.shtml?source=pccj",
      "https://www.finance.sina.cn/app/sfa_macd.shtml?source=pccj",
      "https://finance.sina.cn/app/sfa_macd.shtml"
    ],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T00:14:04.099+03:00",
    "updated": "2025-04-24T00:14:04.099+03:00"
  }
]